- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02631434
Comparison Between Sit-to-stand Test and Six-minute Walk Test in Chronic Obstructive Pulmonary Disease
December 11, 2015 updated by: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Comparison between sit-to-stand test and six minutes walking test in chronic obstructive pulmonary disease patients
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brussels, Belgium
- Clinique Universitaire Saint-Luc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- clinically stable for a minimum of 4 weeks
- no recent infectious exacerbations
Exclusion Criteria:
- musculoskeletal or joint disorders
- contra-indications to perform exercises
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: sit-to-stand
To perform a sit-to-stand test
|
|
|
Active Comparator: six minute walking test
To perform a six minutes walking test
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
number of sit-to-stand movement
Time Frame: 1 minute
|
1 minute
|
|
walked distance
Time Frame: 6 minutes
|
6 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
heart rate
Time Frame: 6 minutes
|
6 minutes
|
|
fraction of oxygen-saturated hemoglobin measured by pulsed oximeter
Time Frame: 6 minutes
|
6 minutes
|
|
breathlessness measured by visual analogic scale
Time Frame: 6 minutes
|
6 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2013
Primary Completion (Actual)
August 1, 2013
Study Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
November 25, 2015
First Submitted That Met QC Criteria
December 11, 2015
First Posted (Estimate)
December 16, 2015
Study Record Updates
Last Update Posted (Estimate)
December 16, 2015
Last Update Submitted That Met QC Criteria
December 11, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STSTCOPD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on sit-to-stand test
-
University Hospital, GrenobleCompletedIdiopathic Pulmonary FibrosisFrance
-
University of ZurichCompletedHealthy IndividualsSwitzerland
-
University Hospital, RouenTerminated
-
Cliniques universitaires Saint-Luc- Université...Completed
-
West Park Healthcare CentreRecruitingChronic Lung DiseaseCanada
-
Centro Universitário Augusto MottaRecruitingHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV | Heart Failure; With DecompensationBrazil
-
Universidad Católica San Antonio de MurciaCompleted
-
Bergman ClinicsUnknownBack Pain | SciaticaNetherlands
-
University of ZurichCompletedPulmonary Disease, Chronic ObstructiveSwitzerland
-
Boston Children's HospitalCompleted